176 related articles for article (PubMed ID: 9925962)
21. Cytokines directly induce degranulation and superoxide production from human eosinophils.
Horie S; Gleich GJ; Kita H
J Allergy Clin Immunol; 1996 Aug; 98(2):371-81. PubMed ID: 8757214
[TBL] [Abstract][Full Text] [Related]
22. Decreased expression of eosinophil peroxidase and major basic protein messenger RNAs during eosinophil maturation.
Gruart V; Truong MJ; Plumas J; Zandecki M; Kusnierz JP; Prin L; Vinatier D; Capron A; Capron M
Blood; 1992 May; 79(10):2592-7. PubMed ID: 1375105
[TBL] [Abstract][Full Text] [Related]
23. Cytokine induction of granule protein synthesis in an eosinophil-inducible human myeloid cell line, AML14.
Paul CC; Ackerman SJ; Mahrer S; Tolbert M; Dvorak AM; Baumann MA
J Leukoc Biol; 1994 Jul; 56(1):74-9. PubMed ID: 8027673
[TBL] [Abstract][Full Text] [Related]
24. Interactions between eotaxin and interleukin-5 in the chemotaxis of primed and non-primed human eosinophils.
Costa GG; Silva RM; Franco-Penteado CF; Antunes E; Ferreira HH
Eur J Pharmacol; 2007 Jul; 566(1-3):200-5. PubMed ID: 17368616
[TBL] [Abstract][Full Text] [Related]
25. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice.
Mould AW; Matthaei KI; Young IG; Foster PS
J Clin Invest; 1997 Mar; 99(5):1064-71. PubMed ID: 9062365
[TBL] [Abstract][Full Text] [Related]
26. The effect of pharmacological PI3Kγ inhibitor on eotaxin-induced human eosinophil functions.
Saito Y; Takeda M; Nishikawa J; Konno Y; Tamaki M; Itoga M; Kobayashi Y; Moritoki Y; Ito W; Chihara J; Ueki S
Pulm Pharmacol Ther; 2014 Apr; 27(2):164-9. PubMed ID: 24333185
[TBL] [Abstract][Full Text] [Related]
27. The impact of eotaxin- and IL-5-induced adhesion and transmigration on eosinophil activity markers.
Fernvik E; Lundahl J; Halldén G
Inflammation; 2000 Feb; 24(1):73-87. PubMed ID: 10704064
[TBL] [Abstract][Full Text] [Related]
28. Human umbilical cord blood-derived eosinophils cultured in the presence of IL-3 and IL-5 respond to fMLP with [Ca2+]i variation and O2- production.
Zardini DM; Heuschling P; Gallois A; Bueb JL; Tschirhart EJ
J Immunol Methods; 1997 Jun; 205(1):1-9. PubMed ID: 9236909
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-12 inhibits eosinophil degranulation and migration but does not promote eosinophil apoptosis.
Davoine F; Ferland C; Chakir J; Lee JE; Adamko DJ; Moqbel R; Laviolette M
Int Arch Allergy Immunol; 2006; 140(4):277-84. PubMed ID: 16735797
[TBL] [Abstract][Full Text] [Related]
30. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo.
Collins PD; Marleau S; Griffiths-Johnson DA; Jose PJ; Williams TJ
J Exp Med; 1995 Oct; 182(4):1169-74. PubMed ID: 7561691
[TBL] [Abstract][Full Text] [Related]
31. A parallel signal-transduction pathway for eotaxin- and interleukin-5-induced eosinophil shape change.
Choi EN; Choi MK; Park CS; Chung IY
Immunology; 2003 Feb; 108(2):245-56. PubMed ID: 12562334
[TBL] [Abstract][Full Text] [Related]
32. A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy.
Hogan SP; Mishra A; Brandt EB; Foster PS; Rothenberg ME
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6681-6. PubMed ID: 10841566
[TBL] [Abstract][Full Text] [Related]
33. Human eotaxin induces alpha 4 and beta 2 integrin-dependent eosinophil accumulation in rat skin in vivo: delayed generation of eotaxin in response to IL-4.
Sanz MJ; Ponath PD; Mackay CR; Newman W; Miyasaka M; Tamatani T; Flanagan BF; Lobb RR; Williams TJ; Nourshargh S; Jose PJ
J Immunol; 1998 Apr; 160(7):3569-76. PubMed ID: 9531320
[TBL] [Abstract][Full Text] [Related]
34. Eotaxin and RANTES enhance 5-oxo-6,8,11,14-eicosatetraenoic acid-induced eosinophil chemotaxis.
Powell WS; Ahmed S; Gravel S; Rokach J
J Allergy Clin Immunol; 2001 Feb; 107(2):272-8. PubMed ID: 11174193
[TBL] [Abstract][Full Text] [Related]
35. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils.
Shinkai A; Yoshisue H; Koike M; Shoji E; Nakagawa S; Saito A; Takeda T; Imabeppu S; Kato Y; Hanai N; Anazawa H; Kuga T; Nishi T
J Immunol; 1999 Aug; 163(3):1602-10. PubMed ID: 10415065
[TBL] [Abstract][Full Text] [Related]
36. The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF.
Kapp A; Zeck-Kapp G; Czech W; Schöpf E
J Invest Dermatol; 1994 Jun; 102(6):906-14. PubMed ID: 7516398
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-8 is a chemo-attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects.
Sehmi R; Cromwell O; Wardlaw AJ; Moqbel R; Kay AB
Clin Exp Allergy; 1993 Dec; 23(12):1027-36. PubMed ID: 10779297
[TBL] [Abstract][Full Text] [Related]
38. Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein.
Dvorak AM; Furitsu T; Letourneau L; Ishizaka T; Ackerman SJ
Am J Pathol; 1991 Jan; 138(1):69-82. PubMed ID: 1987770
[TBL] [Abstract][Full Text] [Related]
39. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions.
Yawalkar N; Shrikhande M; Hari Y; Nievergelt H; Braathen LR; Pichler WJ
J Allergy Clin Immunol; 2000 Dec; 106(6):1171-6. PubMed ID: 11112902
[TBL] [Abstract][Full Text] [Related]
40. Effect of beta2-adrenergic agonists on eosinophil adhesion, superoxide anion generation, and degranulation.
Noguchi T; Nakagome K; Kobayashi T; Ueda Y; Soma T; Nakamoto H; Nagata M
Allergol Int; 2015 Sep; 64 Suppl():S46-53. PubMed ID: 26344080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
